Botanical species · safety record

Symplocos racemosa

The EFSA Compendium of Botanicals holds 3 constituent measurements for Symplocos racemosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Symplocos racemosa Roxb.

3Constituent measurements
0Safety records
2Cited sources
11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Symplocos racemosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bark
  • Bark extract
  • Branch bark
  • Stem bark

What the records describe

Constituents measured

  • Harmine2
  • Harmane alkaloids1

Plant parts

  • Bark3

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Harmane alkaloidsBarkSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
HarmineBarkSolvent extraction≥ 0.226 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
HarmineBarkSolvent extraction≤ 0.268 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kumar, G. S., Swamy, B. M. Vrushabendra., Babu, V. L. Ashoka., Chandanam, Sridhar., Rao, T. Sreenivasa., Tarakaram, K. HPTLC estimation of harmine from the stem bark of Symplocos racemosa Roxb. . Asian journal of chemistry, 2006, vol. 18, no. 4, p. 2851-2855.
  2. Bhusnar, Hanumant U., Nagore, Dheeraj H., Nipanikar, Sanjay U. Phytopharmacological profile of Symplocos racemosa: a review. Pharmacologia, 2014, p. 76-83.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue